Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 20, 2026International Journal of Molecular SciencesOpen Access

Roxadustat Inhibits Osteoclast Differentiation and Function by Disrupting Cell Cycle Exit

View Full Paper
Ask AI
Bookmark
Share

Authors

ALAfang LILZLi ZuoLLLuyao Li

Discussion

Loading...

Member takes

Overview

In vitro study reveals roxadustat inhibits osteoclast differentiation, suggesting new therapeutic potential in bone disorders.

Key Points

  • This study aimed to investigate how roxadustat affects osteoclast differentiation and function.
  • In vitro assays using primary murine bone marrow-derived mononuclear cells.
  • Differentiation induced with M-CSF and RANKL; evaluated cell viability and osteoclast activity.
  • Utilized RNA-seq, flow cytometry, and Western blot techniques.
  • Roxadustat significantly suppressed osteoclast differentiation and bone resorption.
  • Cell cycle analysis showed increased Ki67 and decreased p27, indicating enhanced precursor proliferation.
  • Inhibition of differentiation was partially reversed by the CDK4/6 inhibitor abemaciclib.

Cite This Study

LI et al. (2026) studied this question.

synapsesocial.com/papers/6a362ee4db0793dc1a5368cchttps://doi.org/10.3390/ijms27125506
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1#1948 Transcriptome analysis of the effect of roxadustat on osteoclasts2024
  2. 2Roxadustat Attenuates Adverse Remodeling Following Myocardial Infarction in Mice2024 · 10 citations
  3. 3Long‐Term Excretion of Roxadustat in Urine2024 · 3 citations
  4. 4Roxadustat induced fetal hemoglobin in anemic CKD patients: a dual-center real-world observational cohort study2026
  5. 5Efficacy and Safety of Roxadustat for Anemia in Patients Receiving Chemotherapy for Nonmyeloid Malignancies: A Randomized, Open-Label, Active-Controlled Phase III Study2024 · 6 citations